Skip to content
USZ Zurich
Inselspital
Volv logo
Geninus logo

Areas of expertise

Cell Therapy Quality Assessment

Improve efficacy, predict patient response and longevity the treatment

Patient Safety

Anticipate and reduce the toxicity of Cell Therapy

Reduce Cell Therapy R&D costs

Accelerate cell manufacturing cycles by implementing QC methods derived from single-cell analysis and ScaiVision AI-platform

Best-in-class Plan

Cheetah
Scailyte Logo Element

1.

Get in touch

Let us address your most common challenges

2.

Project setup and data acquisition

We will customise our services to your needs

3.

Data analysis & result delivery

We deliver

What companies we can help

Pharmaceutical companies

We are leveraging single-cell technologies and our best-in-class AI Platform ScaiVision to monitor “desirable functional states”, molecular profiles, and cellular populations in Cell Therapy to enhance Efficacy and reduce Toxicity.

Diagnostic Companies

We are set to improve clinical outcomes and reduce drug development life cycles by leveraging single-cell technologies and our proprietary AI platform ScaiVision.

Hemex

Partner Testimonials

Prof. Dr Michael Mueller

Prof. Dr Michael Mueller

Leading Clinician in Women’s Health & Scientific Advisor

“Our current collaboration with Scailyte in the field of women’s health is a truly innovative approach. We are integrating cutting edge technologies to develop biomarkers that will be the basis for impactful diagnostic solutions.”
Pascal Koenig

Pascal Koenig

Entrepreneur & Chairman of the Board of Directors

“As the co-founder and former CEO of Ava Women, I have experienced the power that big datasets have on the healthcare industry. Scailyte’s mission, proven technology and strong expertise have convinced me to join the team. I am delighted to contribute and assist in bringing Scailyte’s solution to patients around the world.”
Dominique Mégret

Dominique Mégret

Scailyte Board of Directors & Head Swisscom Ventures

“Precision medicine is poised to become a standard in the future, however today it is facing a major obstacle: a data problem. The robust analytical engine of Scailyte makes it an enabler of precision medicine. We decided to support the company because we believe in the technology, as well as in the talented team behind it.”
Prof. Woong-Yang Park

Prof. Woong-Yang Park

Founder and CEO of Geninus

“Geninus aims to implement single-cell genome analysis techniques to facilitate personalized patient care. Scailyte’s machine learning model will add value to the single-cell gene expression profile of patients. Through collaboration with Scailyte, we hope to provide prognostic methods for immunotherapy response in precision medicine clinics.”

Recent News

VACANCY: Regulatory Affairs / Quality Management Specialist

We are currently developing a first-in-class in vitro diagnostic tool for Endometriosis aiming at cu

Read more

Recent News

Scailyte Webinar - Why single-cell technologies are vital for Endometriosis research

Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of th

Read more

Recent News

Single-Cell Discovery Grant in Oncology and Immunology

Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunolo

Read more

Recent News

Scailyte and Lexogen create a joint biomarker discovery workflow for precision medicine companies

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Recent News

Scailyte Quarterly Update, June 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

Scailyte announces Michael Brenner, of Harvard Medical School, as an advisor to its Board of Directors

Artificial Intelligence (AI)-driven biomarker discovery innovator Scailyte announced today that Mich

Read more

Recent News

Scailyte Quarterly Update, April 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

01 /04

VACANCY: Regulatory Affairs / Quality Management Specialist

We are currently developing a first-in-class in vitro diagnostic tool for Endometriosis aiming at cu

Read more

Scailyte Webinar - Why single-cell technologies are vital for Endometriosis research

Prof. Dr Michael D. Mueller is an expert in endometriosis and women’s health. The complexity of th

Read more

Recent News

02 /04

Single-Cell Discovery Grant in Oncology and Immunology

Open grant call of up to 100K Euro aimed at addressing unmet clinical needs in Oncology and Immunolo

Read more

Scailyte and Lexogen create a joint biomarker discovery workflow for precision medicine companies

Scailyte, a single-cell biomarker discovery company and Lexogen, a leader in RNA sequencing solution

Read more

Recent News

03 /04

Scailyte Quarterly Update, June 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Scailyte announces Michael Brenner, of Harvard Medical School, as an advisor to its Board of Directors

Artificial Intelligence (AI)-driven biomarker discovery innovator Scailyte announced today that Mich

Read more

Recent News